Volume 21, Number 10—October 2015
Research
Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002–2013
Table 3
Characteristic | No. (%) |
---|---|
Sex | |
M | 10 (76.9) |
F |
3 (23.1) |
Age group, y | |
0–9 | 2 (15.4) |
10–19 | 2 (15.4) |
20–29 | 2 (15.4) |
30–39 | 2 (15.4) |
40–49 | 1 (7.7) |
50–59 | 1 (7.7) |
60–69 | 1 (7.7) |
70–79 | 1 (7.7) |
>80 |
1 (7.7) |
Symptoms† | |
Rash, any reported | 4 (30.8) |
Influenza-like illness | 9 (69.2) |
EM, physician-diagnosed | 4 (30.8) |
Brief recurrent joint swelling | 2 (15.4) |
Bell palsy | 3 (23.1) |
Any nervous system sign or symptom | 2 (15.4) |
Cardiovascular system signs | 2 (15.4) |
*EM, erythema migrans; LD, Lyme disease.
†More than 1 symptom might be reported per case-patient. Rash, any reported, includes EM. Cardiovascular system signs include atrioventricular block, mycarditis, other.
Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.